Egfr-mutant Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Egfr-mutant Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: A Study to Investigate Safety, Tolerability, PK and Anti-tumor Activity of TRX-221 in EGFRm NSCLC Patients [Phase 1, Phase 2]
A Phase 1/2 trial of TRX-221 in EGFR-mutant non-small cell lung cancer has been terminated; the update covers safety, tolerability, pharmaco…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Firmonertinib 160 mg in Patients With EGFR-Mutant Advanced NSCLC Demonstrating SD After 8 Week Induction With Firmonertinib 80 mg [Phase 2]
Phase 2 trial of Firmonertinib in EGFR-mutant advanced non-small cell lung cancer shows disease stabilization after an 8-week induction with…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Special Investigation for VIZIMPRO Tablets (Secondary Data Collection Study; Safety and Efficacy of VIZIMPRO Under Japanese Medical Practice)
A completed special investigation collecting safety and efficacy data for VIZIMPRO (dacomitinib) in EGFR mutation-positive non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients [Phase 2]
A Phase 2 neoadjuvant trial for EGFR-mutated non-small cell lung cancer (Neo-DIANA) was terminated, with results posted in 2025.
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Assessing the Effect of DZD9008 on the Pharmacokinetics of the Cocktail Probes Representative for CYP3A4, P-gp, BCRP and OATP1B1 in Patients with EGFR or HER2 Mutant Advanced Non-small Cell Lung Cancer (WU-KONG19) [Phase 1]
Phase 1 trial update evaluating how DZD9008 influences the pharmacokinetics of cocktail probe drugs reflecting CYP3A4, P-gp, BCRP, and OATP1…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-20Clinical Trial Update: A Study to Learn About How Itraconazole and Carbamazepine Affect the Level of BAY2927088 in the Blood When These Drugs Are Taken Together by Healthy Participants [Phase 1]
Phase 1 study evaluating how itraconazole and carbamazepine affect BAY2927088 blood levels in healthy participants; study completed.
-
CLINICAL_TRIALS trial_result · 2024-06-17Clinical Trial Update: Phase II Trial of Almonertinib Plus Lastet for EGFR+ Non-small Cell Lung Cancer [Phase 2]
A Phase II trial investigating Almonertinib in combination with Lastet for EGFR-positive non-small cell lung cancer; the study is not yet re…
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: A Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy [Phase 2]
Phase 2 trial evaluating lazertinib as consolidation therapy after chemoradiation in locally advanced, unresectable EGFR-mutant non-small ce…
-
CLINICAL_TRIALS trial_result · 2022-06-22Clinical Trial Update: Erlotinib Hydrochloride and Onalespib Lactate in Treating Patients With Recurrent or Metastatic EGFR-Mutant Non-small Cell Lung Cancer [Phase 1, Phase 2]
This clinical trial update reports results from a Phase 1/2 study of erlotinib hydrochloride combined with onalespib lactate in patients wit…